November 20, 2018: Most content in the UA Campus Repository is not accessible using the search/browse functions due to a performance bug; we are actively working to resolve this issue. If you are looking for content you know is in the repository, but cannot get to it, please email us at email@example.com with your questions and we'll make sure to get the content to you.
Human prostate luminal cell differentiation requires NOTCH3 induction by p38-MAPK and MYC
AffiliationUniv Arizona, Ctr Canc, Dept Cellular & Mol Med
MetadataShow full item record
PublisherCOMPANY OF BIOLOGISTS LTD
CitationHuman prostate luminal cell differentiation requires NOTCH3 induction by p38-MAPK and MYC 2017, 130 (11):1952 Journal of Cell Science
JournalJournal of Cell Science
Rights© 2017. Published by The Company of Biologists Ltd
Collection InformationThis item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at firstname.lastname@example.org.
AbstractMany pathways dysregulated in prostate cancer are also involved in epithelial differentiation. To better understand prostate tumor initiation, we sought to investigate specific genes and mechanisms required for normal basal to luminal cell differentiation. Utilizing human prostate basal epithelial cells and an in vitro differentiation model, we tested the hypothesis that regulation of NOTCH3 by the p38 MAPK family (hereafter p38-MAPK), via MYC, is required for luminal differentiation. Inhibition (SB202190 and BIRB796) or knockdown of p38a (also known as MAPK14) and/or p38d (also known as MAPK13) prevented proper differentiation. Additionally, treatment with a gamma-secretase inhibitor (RO4929097) or knockdown of NOTCH1 and/or NOTCH3 greatly impaired differentiation and caused luminal cell death. Constitutive p38-MAPK activation through MKK6(CA) increased NOTCH3 (but not NOTCH1) mRNA and protein levels, which was diminished upon MYC inhibition (10058-F4 and JQ1) or knockdown. Furthermore, we validated two NOTCH3 enhancer elements through a combination of enhancer (e) RNA detection (BruUV-seq) and luciferase reporter assays. Finally, we found that the NOTCH3 mRNA half-life increased during differentiation or upon acute p38-MAPK activation. These results reveal a new connection between p38-MAPK, MYC and NOTCH signaling, demonstrate two mechanisms of NOTCH3 regulation and provide evidence for NOTCH3 involvement in prostate luminal cell differentiation.
Note12 month embargo; Published online June 1, 2017.
VersionFinal published version
SponsorsU.S. Department of Defense Prostate Cancer Research Program [W81XWH-14-1-0479]; Association for International Cancer Research (Worldwide Cancer Research) [11-0082]; Van Andel Research Institute; University of Arizona
- p38 MAPK regulates the Wnt inhibitor Dickkopf-1 in osteotropic prostate cancer cells.
- Authors: Browne AJ, Göbel A, Thiele S, Hofbauer LC, Rauner M, Rachner TD
- Issue date: 2016 Feb 25
- The p38 MAPK pathway mediates aryl propionic acid induced messenger rna stability of p75 NTR in prostate cancer cells.
- Authors: Quann EJ, Khwaja F, Djakiew D
- Issue date: 2007 Dec 1
- G Protein-coupled Receptor 40 (GPR40) and Peroxisome Proliferator-activated Receptor γ (PPARγ): AN INTEGRATED TWO-RECEPTOR SIGNALING PATHWAY.
- Authors: Wang S, Awad KS, Elinoff JM, Dougherty EJ, Ferreyra GA, Wang JY, Cai R, Sun J, Ptasinska A, Danner RL
- Issue date: 2015 Aug 7
- Escherichia coli-derived and Staphylococcus aureus-derived extracellular vesicles induce MUC5AC expression via extracellular signal related kinase 1/2 and p38 mitogen-activated protein kinase in human airway epithelial cells.
- Authors: Bae CH, Choi YS, Song SY, Kim YK, Kim YD
- Issue date: 2017 Jan
- Role of C/EBP-β, p38 MAPK, and MKK6 in IL-1β-mediated C3 gene regulation in astrocytes.
- Authors: Maranto J, Rappaport J, Datta PK
- Issue date: 2011 Apr